At this time, generic versions of Yasmin are available. All of them have been given an "AB" rating by the FDA, which means they should be equivalent to brand-name Yasmin. However, generic medications are allowed to have different inactive ingredients, which may present a problem for people with certain sensitivities.
Yasmin is made by Bayer HealthCare Pharmaceuticals. However, generic Yasmin is also available. Because a less-expensive, generic version of Yasmin is available, you may find that your insurance company will not cover brand-name Yasmin.
Generic Yasmin Names
Currently, generic Yasmin is sold under the names Ocella™, Syeda™, and Zarah™. Because the generic names of birth control pills can be very confusing (the names are long, and multiple different products can have the same generic name but different strengths), manufacturers of generic birth control pills give their versions a "brand name" to avoid confusion. Ocella, Syeda, and Zarah are still generics, even though they seem like brand-name products, due to their names.
One generic version made by Lupin Pharmaceuticals, though, is sold under the standard generic name of drospirenone/ethinyl estradiol.
Are Ocella and Zarah as Good as Yasmin?
All generic medications must undergo certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns each generic a rating.
An "AB" rating means that the FDA has determined that a generic medication is equivalent to a brand-name medication. All of the generic versions of Yasmin have an "AB" rating, meaning they should be equivalent to the brand-name product.
However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include fillers or dyes or other ingredients that may cause problems for people with allergies or sensitivities.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed April 7, 2011.
Watson Pharmaceuticals, Inc.; Watson's generic Yasmin(R) receives FDA approval (9/7/2010). Watson Web site. Available at: http://ir.watson.com/phoenix.zhtml?c=65778&p=irol-newsArticle&ID=1467958, Accessed September 17, 2010.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click